US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 27.630
  • +2.200+8.65%
Close Nov 6 16:00 ET
  • 27.630
  • 0.0000.00%
Post 17:24 ET
1.83BMarket Cap-10047P/E (TTM)

Celldex Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.84%-29.33M
-42.25%-40.64M
-3.43%-107.29M
-49.49%-32.53M
46.03%-18.99M
-22.26%-27.2M
-16.45%-28.57M
-70.31%-103.73M
-49.85%-21.76M
-114.95%-35.19M
Net income from continuing operations
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
-30.96%-26.78M
Operating gains losses
--0
--8K
----
----
----
----
----
108.33%2K
200.00%1K
-5,700.00%-56K
Depreciation and amortization
5.42%797K
6.75%775K
3.87%3.01M
12.78%759K
14.31%767K
2.02%756K
-10.48%726K
-5.61%2.9M
-13.38%673K
-10.77%671K
Deferred tax
----
----
--0
----
----
----
----
--0
----
----
Other non cash items
----
----
----
----
----
----
----
-388.40%-6.86M
--0
--0
Change In working capital
286.99%2.82M
-314.25%-12.5M
445.36%13.46M
7,563.08%4.98M
195.79%13.01M
-109.85%-1.51M
46.90%-3.02M
-269.83%-3.9M
-96.30%65K
-728.56%-13.58M
-Change in receivables
-4.93%1.14M
95.55%-43K
-1,203.43%-2.28M
-1,403.80%-2.38M
-45.65%-134K
719.18%1.2M
-1,261.97%-967K
-111.12%-175K
-732.00%-158K
-137.86%-92K
-Change in prepaid assets
121.52%599K
-328.10%-6.21M
161.64%5.9M
352.01%4.14M
226.39%1.82M
-108.15%-2.78M
138.08%2.72M
-411.60%-9.57M
-521.54%-1.64M
177.68%557K
-Change in payables and accrued expense
258.58%1.71M
-38.66%-4.78M
200.48%9.38M
61.34%3.88M
163.18%8.48M
-97.17%478K
-25.93%-3.45M
-14.51%3.12M
26.74%2.4M
-635.22%-13.42M
-Change in other current assets
----
----
---3K
--0
--0
----
----
--0
--0
--0
-Change in other current liabilities
-60.00%-632K
-10.87%-1.47M
-83.05%462K
-23.69%-663K
555.93%2.85M
-2.07%-395K
-131.01%-1.33M
161.88%2.73M
2.55%-536K
-591.34%-624K
Cash from discontinued investing activities
Operating cash flow
-7.84%-29.33M
-42.25%-40.64M
-3.43%-107.29M
-49.49%-32.53M
46.03%-18.99M
-22.26%-27.2M
-16.45%-28.57M
-70.31%-103.73M
-49.85%-21.76M
-114.95%-35.19M
Investing cash flow
Cash flow from continuing investing activities
-4,114.00%-46.72M
-699.61%-315.21M
-217.61%-105.78M
-648.36%-171.16M
-49.51%11.65M
-95.40%1.16M
406.45%52.57M
141.61%89.94M
264.76%31.21M
110.17%23.07M
Net PPE purchase and sale
33.17%-274K
41.20%-344K
0.55%-1.82M
-183.40%-666K
54.49%-157K
39.08%-410K
-1.74%-585K
-46.36%-1.83M
33.62%-235K
-86.49%-345K
Net investment purchase and sale
-3,051.02%-46.45M
-692.37%-314.87M
-213.37%-103.96M
-642.15%-170.5M
-49.44%11.8M
-93.94%1.57M
385.20%53.15M
142.66%91.7M
269.15%31.45M
110.30%23.34M
Net other investing changes
----
----
----
----
----
----
----
155.56%69K
--0
----
Cash from discontinued investing activities
Investing cash flow
-4,114.00%-46.72M
-699.61%-315.21M
-217.61%-105.78M
-648.36%-171.16M
-49.51%11.65M
-95.40%1.16M
406.45%52.57M
141.61%89.94M
264.76%31.21M
110.17%23.07M
Financing cash flow
Cash flow from continuing financing activities
2,690.98%3.71M
62,740.35%436.11M
5,259.62%218.46M
15,482.37%217.37M
-88.86%257K
87.32%133K
128.29%694K
-98.50%4.08M
227.46%1.4M
-99.15%2.31M
Net common stock issuance
--0
--432.3M
--216.22M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
2,690.98%3.71M
449.57%3.81M
-45.14%2.24M
-17.42%1.15M
-88.86%257K
87.32%133K
128.29%694K
64.42%4.08M
227.46%1.4M
15.07%2.31M
Cash from discontinued financing activities
Financing cash flow
2,690.98%3.71M
62,740.35%436.11M
5,259.62%218.46M
15,482.37%217.37M
-88.86%257K
87.32%133K
128.29%694K
-98.50%4.08M
227.46%1.4M
-99.15%2.31M
Net cash flow
Beginning cash position
112.62%115.08M
18.30%34.81M
-24.82%29.43M
13.73%21.13M
-0.62%28.22M
113.98%54.12M
-24.82%29.43M
-10.71%39.14M
-74.26%18.58M
-34.63%28.4M
Current changes in cash
-179.31%-72.34M
225.03%80.26M
155.44%5.39M
26.13%13.68M
27.79%-7.09M
-933.30%-25.9M
278.30%24.69M
-106.99%-9.71M
132.83%10.85M
-134.16%-9.82M
End cash Position
51.43%42.74M
112.62%115.08M
18.30%34.81M
18.30%34.81M
13.73%21.13M
-0.62%28.22M
113.98%54.12M
-24.82%29.43M
-24.82%29.43M
-74.26%18.58M
Free cash flow
-7.23%-29.6M
-40.57%-40.98M
-3.36%-109.11M
-50.93%-33.2M
46.11%-19.15M
-20.46%-27.61M
-16.11%-29.15M
-69.83%-105.56M
-47.86%-22M
-114.63%-35.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022 (Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.84%-29.33M -42.25%-40.64M -3.43%-107.29M -49.49%-32.53M 46.03%-18.99M -22.26%-27.2M -16.45%-28.57M -70.31%-103.73M -49.85%-21.76M -114.95%-35.19M
Net income from continuing operations -17.51%-35.84M -11.74%-32.81M -25.91%-141.43M -63.50%-43.31M -42.85%-38.26M 15.28%-30.5M -27.38%-29.36M -59.30%-112.33M -31.46%-26.49M -30.96%-26.78M
Operating gains losses --0 --8K ---- ---- ---- ---- ---- 108.33%2K 200.00%1K -5,700.00%-56K
Depreciation and amortization 5.42%797K 6.75%775K 3.87%3.01M 12.78%759K 14.31%767K 2.02%756K -10.48%726K -5.61%2.9M -13.38%673K -10.77%671K
Deferred tax ---- ---- --0 ---- ---- ---- ---- --0 ---- ----
Other non cash items ---- ---- ---- ---- ---- ---- ---- -388.40%-6.86M --0 --0
Change In working capital 286.99%2.82M -314.25%-12.5M 445.36%13.46M 7,563.08%4.98M 195.79%13.01M -109.85%-1.51M 46.90%-3.02M -269.83%-3.9M -96.30%65K -728.56%-13.58M
-Change in receivables -4.93%1.14M 95.55%-43K -1,203.43%-2.28M -1,403.80%-2.38M -45.65%-134K 719.18%1.2M -1,261.97%-967K -111.12%-175K -732.00%-158K -137.86%-92K
-Change in prepaid assets 121.52%599K -328.10%-6.21M 161.64%5.9M 352.01%4.14M 226.39%1.82M -108.15%-2.78M 138.08%2.72M -411.60%-9.57M -521.54%-1.64M 177.68%557K
-Change in payables and accrued expense 258.58%1.71M -38.66%-4.78M 200.48%9.38M 61.34%3.88M 163.18%8.48M -97.17%478K -25.93%-3.45M -14.51%3.12M 26.74%2.4M -635.22%-13.42M
-Change in other current assets ---- ---- ---3K --0 --0 ---- ---- --0 --0 --0
-Change in other current liabilities -60.00%-632K -10.87%-1.47M -83.05%462K -23.69%-663K 555.93%2.85M -2.07%-395K -131.01%-1.33M 161.88%2.73M 2.55%-536K -591.34%-624K
Cash from discontinued investing activities
Operating cash flow -7.84%-29.33M -42.25%-40.64M -3.43%-107.29M -49.49%-32.53M 46.03%-18.99M -22.26%-27.2M -16.45%-28.57M -70.31%-103.73M -49.85%-21.76M -114.95%-35.19M
Investing cash flow
Cash flow from continuing investing activities -4,114.00%-46.72M -699.61%-315.21M -217.61%-105.78M -648.36%-171.16M -49.51%11.65M -95.40%1.16M 406.45%52.57M 141.61%89.94M 264.76%31.21M 110.17%23.07M
Net PPE purchase and sale 33.17%-274K 41.20%-344K 0.55%-1.82M -183.40%-666K 54.49%-157K 39.08%-410K -1.74%-585K -46.36%-1.83M 33.62%-235K -86.49%-345K
Net investment purchase and sale -3,051.02%-46.45M -692.37%-314.87M -213.37%-103.96M -642.15%-170.5M -49.44%11.8M -93.94%1.57M 385.20%53.15M 142.66%91.7M 269.15%31.45M 110.30%23.34M
Net other investing changes ---- ---- ---- ---- ---- ---- ---- 155.56%69K --0 ----
Cash from discontinued investing activities
Investing cash flow -4,114.00%-46.72M -699.61%-315.21M -217.61%-105.78M -648.36%-171.16M -49.51%11.65M -95.40%1.16M 406.45%52.57M 141.61%89.94M 264.76%31.21M 110.17%23.07M
Financing cash flow
Cash flow from continuing financing activities 2,690.98%3.71M 62,740.35%436.11M 5,259.62%218.46M 15,482.37%217.37M -88.86%257K 87.32%133K 128.29%694K -98.50%4.08M 227.46%1.4M -99.15%2.31M
Net common stock issuance --0 --432.3M --216.22M ---- ---- --0 --0 --0 ---- ----
Proceeds from stock option exercised by employees 2,690.98%3.71M 449.57%3.81M -45.14%2.24M -17.42%1.15M -88.86%257K 87.32%133K 128.29%694K 64.42%4.08M 227.46%1.4M 15.07%2.31M
Cash from discontinued financing activities
Financing cash flow 2,690.98%3.71M 62,740.35%436.11M 5,259.62%218.46M 15,482.37%217.37M -88.86%257K 87.32%133K 128.29%694K -98.50%4.08M 227.46%1.4M -99.15%2.31M
Net cash flow
Beginning cash position 112.62%115.08M 18.30%34.81M -24.82%29.43M 13.73%21.13M -0.62%28.22M 113.98%54.12M -24.82%29.43M -10.71%39.14M -74.26%18.58M -34.63%28.4M
Current changes in cash -179.31%-72.34M 225.03%80.26M 155.44%5.39M 26.13%13.68M 27.79%-7.09M -933.30%-25.9M 278.30%24.69M -106.99%-9.71M 132.83%10.85M -134.16%-9.82M
End cash Position 51.43%42.74M 112.62%115.08M 18.30%34.81M 18.30%34.81M 13.73%21.13M -0.62%28.22M 113.98%54.12M -24.82%29.43M -24.82%29.43M -74.26%18.58M
Free cash flow -7.23%-29.6M -40.57%-40.98M -3.36%-109.11M -50.93%-33.2M 46.11%-19.15M -20.46%-27.61M -16.11%-29.15M -69.83%-105.56M -47.86%-22M -114.63%-35.54M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- Unqualified Opinion -- -- -- -- -- -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data